{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:27:16Z","timestamp":1783632436261,"version":"3.55.0"},"reference-count":77,"publisher":"Index Copernicus","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pol Przegl Chir"],"published-print":{"date-parts":[[2025,1,22]]},"abstract":"<ns3:p>&lt;b&gt;Introduction:&lt;\/b&gt; Chronic kidney disease (CKD) is a global public health problem, occurring more frequently in developed countries. In Poland, it affects approximately 4 million people, which constitutes 10.8% of the population. End-stage renal disease (ESRD) requires renal replacement therapy \u2013 dialysis therapy or kidney transplantation. Kidney transplantation, supported by immunosuppressive therapy, is the preferred method of treating ESRD, improving the quality and length of life of patients.&lt;b&gt;Aim and Methods:&lt;\/b&gt; The aim of the study was to determine the long-term effects of kidney transplantation, including proper graft function, the frequency of adverse effects of immunosuppressive therapy, the degree of patient compliance with therapeutic recommendations, and the incidence of malignancies. A survey was conducted in a group of 137 patients who underwent kidney transplantation between 2006 and 2015. Hospitalization data were also analyzed, including age, body weight and blood type of the recipient.&lt;b&gt;Results:&lt;\/b&gt; Of the 137 patients studied, 61 were women and 76 were men. The mean age of the patients was 45.1 years. The most common etiology of CKD was glomerulonephritis. After kidney transplantation, 86.86% of patients declared normal graft function. Post-transplant weight gain was noted in 75.18% of patients. 11.68% of recipients developed malignancies, with an average time from transplantation to diagnosis of 5.1 years. Of the patients with cancer, 93.75% maintained normal graft function.&lt;b&gt;Conclusions:&lt;\/b&gt; Long-term effects of kidney transplantation are satisfactory, with a high percentage of patients maintaining normal graft function. Complications associated with immunosuppressive therapy are comparable to literature data. It is necessary to increase patient awareness of modifiable risk factors to improve treatment outcomes. The incidence of malignancy after transplantation is lower than in the literature, but the methodological limitations of the study must be taken into account. Cancer treatment had no significant effect on graft function in most cases.<\/ns3:p>","DOI":"10.5604\/01.3001.0054.9677","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T12:12:42Z","timestamp":1741090362000},"page":"1-9","source":"Crossref","is-referenced-by-count":7,"title":["The assesement of the long-term effects of kidney transplantation, including the incidence of malignant tumors, in recipients operated on between 2006 and 2015 \u2013 a cohort study and literature review."],"prefix":"10.5604","volume":"97","author":[{"given":"Wojciech","family":"Ciesielski","sequence":"first","affiliation":[{"name":"Department of General and Transplant Surgery, Medical University of Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weronika","family":"Fr\u0105k","sequence":"additional","affiliation":[{"name":"Student Scientific Circle at the Department of General and Transplant Surgery of the Medical University of Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julita","family":"Gmitrzuk","sequence":"additional","affiliation":[{"name":"Student Scientific Circle at the Department of General and Transplant Surgery of the Medical University of Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Kuczy\u0144ski","sequence":"additional","affiliation":[{"name":"Student Scientific Circle at the Department of General and Transplant Surgery of the Medical University of Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7589-1141","authenticated-orcid":false,"given":"Tomasz","family":"Klimczak","sequence":"additional","affiliation":[{"name":"Department of General and Transplant Surgery, Medical University of Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2999-5454","authenticated-orcid":false,"given":"Adam","family":"Durczy\u0144ski","sequence":"additional","affiliation":[{"name":"Department of General and Transplant Surgery, Medical University of Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Strzelczyk","sequence":"additional","affiliation":[{"name":"Department of General and Transplant Surgery, Medical University of Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Hogendorf","sequence":"additional","affiliation":[{"name":"Department of General and Transplant Surgery, Medical University of Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3689","reference":[{"key":"627124r1","doi-asserted-by":"crossref","unstructured":"Zdrojewski \u0141., Zdrojewski T., Rutkowski M. et al.: Prevalence of chronic kidney diseasein a representative sample of the Polish population: results of the NATPOL 2011 survey.Nephrol Dial Transplant., 2016; 31(3): 433\u2013439. doi: 10.1093\/ndt\/gfv369.","DOI":"10.1093\/ndt\/gfv369"},{"key":"627124r2","doi-asserted-by":"crossref","unstructured":"Zdrojewski \u0141., Kr\u00f3l E., Rutkowski B. et al.: Chronic kidney disease in Polishelderly population aged 75+: results of the WOBASZ Senior Survey. Int UrolNephrol., 2017; 49(4): 669\u2013676. doi: 10.1007\/s11255-016-1477-7.","DOI":"10.1007\/s11255-016-1477-7"},{"key":"627124r3","doi-asserted-by":"crossref","unstructured":"Renke M., Parszuto J., Rybacki M. et al.: Chronic kidney disease \u2013 The relevantinformation for an occupational physician. Medycyna Pracy., 2018; 69(1): 67\u201375.doi: 10.13075\/mp.5893.00624.","DOI":"10.13075\/mp.5893.00624"},{"key":"627124r4","unstructured":"KDIGO 2012 Clinical Practice Guideline for the Evaluation and Managementof Chronic Kidney Disease. Kidney International Supplements, 2013, 3: 1\u2013150."},{"key":"627124r5","doi-asserted-by":"crossref","unstructured":"Romagnani P., Remuzzi G., Glassock R. et al.; Chronic kidney disease. Nat RevDis Primers. 2017; 3: 17088. doi: 10.1038\/nrdp.2017.88.","DOI":"10.1038\/nrdp.2017.88"},{"key":"627124r6","unstructured":"Kalinowska A., Kowalczyk M., Pruszko C., Prystacki T.: Dost\u0119p do \u015bwiadcze\u0144nefrologicznych w Polsce. Raport 2019."},{"key":"627124r7","doi-asserted-by":"crossref","unstructured":"Lee B.J., McCulloch C.E., Grimes B.A. et al.: Refining the Policy for Timing ofKidney Transplant Waitlist Qualification. Transplant Direct. 2017; 3(8): e195.doi: 10.1097\/TXD.0000000000000706.","DOI":"10.1097\/TXD.0000000000000706"},{"key":"627124r8","unstructured":"Durlik M.: History of kidney transplantation in Poland. G Ital Nefrol., 2018;35(Suppl 70): 84\u201386."},{"key":"627124r9","unstructured":"Czerwi\u0144ski J., Malanowski P., Grzywacz A., \u0141\u0119czycka A.: Poltransplant BiuletynInformacyjny"},{"key":"627124r10","unstructured":"Durlik M., Danielewicz R.: Zalecenia dotycz\u0105ce leczenie immunosupresyjnegou biorc\u00f3w narz\u0105d\u00f3w unaczynionych Polskiego Towarzystwa Transplantacyjnego.Fundacja Zjednoczeni dla Transplantacji, Warszawa 2021."},{"key":"627124r11","doi-asserted-by":"crossref","unstructured":"Immunosuppression and Results in Renal Transplantation. Jamal Bamoulidet al. European Urology Supplements., 2016; 15(9): 415\u2013429. doi: 10.1016\/j.eursup.2016.04.011.","DOI":"10.1016\/j.eursup.2016.04.011"},{"key":"627124r12","doi-asserted-by":"crossref","unstructured":"Lim M.A., Kohli J., Bloom R.D.: Immunosuppression for kidney transplantation:Where are we now and where are we going? Transplant Rev (Orlando).,2017; 31(1): 10\u201317. doi: 10.1016\/j.trre.2016.10.006.","DOI":"10.1016\/j.trre.2016.10.006"},{"key":"627124r13","unstructured":"CHARAKTERYSTYKA PRODUKTU LECZNICZEGO. Tacrolimus Accordkapsu\u0142ki twarde. http:\/\/chpl.com.pl\/data_files\/2012-12-12_Tacrolimus_Accord_SPC_clean.pdf (13.08.2024)."},{"key":"627124r14","unstructured":"Transplantation GOoDa. Worldwide donation data. Global Observation onDonation and Transplantation 2019. Contract No.: 24.04. http:\/\/www.transplant-observatory.org\/download\/2016-activity-data-report\/ (13.08.2024)."},{"key":"627124r15","doi-asserted-by":"crossref","unstructured":"Poggio E.D., Augustine J.J., Arrigain S., Brennan D.C., Schold J.D.: Long-termkidney transplant graft survival-Making progress when most needed. AmJ Transplant., 2021; 21(8): 2824\u20132832. doi: 10.1111\/ajt.16463.","DOI":"10.1111\/ajt.16463"},{"key":"627124r16","doi-asserted-by":"crossref","unstructured":"Coresh J., Astor B.C., Greene T., Eknoyan G., Levey A.S.: Prevalence of chronickidney disease and decreased kidney function in the adult US population:Third National Health and Nutrition Examination Survey. Am J Kidney Dis.,2003; 41(1): 1\u201312. doi: 10.1053\/ajkd.2003.50007.","DOI":"10.1053\/ajkd.2003.50007"},{"key":"627124r17","doi-asserted-by":"crossref","unstructured":"Plantinga L.C., Crews D.C., Coresh J. et al.: Prevalence of chronic kidney diseasein US adults with undiagnosed diabetes or prediabetes. Clin J Am SocNephrol., 2010; 5(4): 673\u2013682. doi: 10.2215\/CJN.07891109.","DOI":"10.2215\/CJN.07891109"},{"key":"627124r18","doi-asserted-by":"crossref","unstructured":"Oniscu G.C., Brown H., Forsythe J.L.: How old is old for transplantation? AmJ Transplant., 2004; 4(12): 2067\u20132074. doi: 10.1111\/j.1600-6143.2004.00622.x.","DOI":"10.1111\/j.1600-6143.2004.00622.x"},{"key":"627124r19","doi-asserted-by":"crossref","unstructured":"Saran R., Li Y., Robinson B.: US Renal Data System 2014 Annual Data Report:Epidemiology of Kidney Disease in the United States. Am J Kidney Dis., 2015;66(1 Suppl 1): Svii, S1\u2013305. doi: 10.1053\/j.ajkd.2015.05.001.","DOI":"10.1053\/j.ajkd.2015.07.013"},{"key":"627124r20","doi-asserted-by":"crossref","unstructured":"Ashby V.B., Kalbfleisch J.D., Wolfe R.A. et al.: Geographic variability in accessto primary kidney transplantation in the United States, 1996-2005. AmJ Transplant., 2007; 7(5 Pt 2): 1412\u20131423. doi: 10.1111\/j.1600-6143.2007.01785.x.","DOI":"10.1111\/j.1600-6143.2007.01785.x"},{"key":"627124r21","unstructured":"Poltransplant, Statystyka 2021 r. https:\/\/www.poltransplant.org.pl\/statystyka_2021.html (13.08.2024)."},{"key":"627124r22","doi-asserted-by":"crossref","unstructured":"Stel V.S., Kramar R., Leivestad T. et al.: Time trend in access to the waiting listand renal transplantation: a comparison of four European countries. NephrolDial Transplant., 2012; 27(9): 3621\u20133631. doi: 10.1093\/ndt\/gfs089.","DOI":"10.1093\/ndt\/gfs089"},{"key":"627124r23","doi-asserted-by":"crossref","unstructured":"Tapiawala S.N., Tinckam K.J., Cardella C.J. et al.: Delayed graft function andthe risk for death with a functioning graft. J Am Soc Nephrol., 2010; 21(1):153\u2013161. doi: 10.1681\/ASN.2009040412.","DOI":"10.1681\/ASN.2009040412"},{"key":"627124r24","doi-asserted-by":"crossref","unstructured":"Bahl D., Haddad Z., Datoo A., Qazi Y.A.: Delayed graft function in kidney transplantation.Curr Opin Organ Transplant., 2019; 24(1): 82\u201386. doi: 10.1097\/MOT.0000000000000604.","DOI":"10.1097\/MOT.0000000000000604"},{"key":"627124r25","doi-asserted-by":"crossref","unstructured":"Zens T.J., Danobeitia J.S., Leverson G. et al.: The impact of kidney donor profileindex on delayed graft function and transplant outcomes: A single-centeranalysis. Clin Transplant., 2018; 32(3): e13190. doi: 10.1111\/ctr.13190.","DOI":"10.1111\/ctr.13190"},{"key":"627124r26","doi-asserted-by":"crossref","unstructured":"Malyszko J., Lukaszyk E., Glowinska I., Durlik M.: Biomarkers of delayed graftfunction as a form of acute kidney injury in kidney transplantation. Sci Rep.,2015; 5: 11684. doi: 10.1038\/srep11684.","DOI":"10.1038\/srep11684"},{"key":"627124r27","unstructured":"Expanded Criteria Donors (ECD), UC Davis Transplant Center. https:\/\/health.ucdavis.edu\/transplant\/nonlivingdonors\/expanded-criteria-donors.html(13.08.2024)."},{"key":"627124r28","doi-asserted-by":"crossref","unstructured":"Joachim E., Gardezi A.I., Chan M.R. et al.: Association of Pre-Transplant DialysisModality and Post-Transplant Outcomes: A Meta-Analysis. Perit DialInt., 2017; 37(3): 259\u2013265. doi: 10.3747\/pdi.2016.00011.","DOI":"10.3747\/pdi.2016.00011"},{"key":"627124r29","doi-asserted-by":"crossref","unstructured":"Altheaby A., Alajlan N., Shaheen M.F. et al.: Weight gain after renal transplant:Incidence, risk factors, and outcomes. PLoS One., 2022; 17(6): e0268044. doi:10.1371\/journal.pone.0268044.","DOI":"10.1371\/journal.pone.0268044"},{"key":"627124r30","unstructured":"Aksoy N.: Weight Gain After Kidney Transplant. Exp Clin Transplant., 2016;14(Suppl 3): 138\u2013140."},{"key":"627124r31","doi-asserted-by":"crossref","unstructured":"Kurnatowska I., Ma\u0142yska A., Wysocka K. et al.: Long-Term Effect of Body MassIndex Changes on Graft Damage Markers in Patients After Kidney Transplantation.Ann Transplant., 2016; 21: 626\u2013631. doi: 10.12659\/aot.899393.","DOI":"10.12659\/AOT.899393"},{"key":"627124r32","doi-asserted-by":"crossref","unstructured":"Altheaby A., Alajlan N., Shaheen M.F. et al.: Weight gain after renal transplant:Incidence, risk factors, and outcomes. PLoS One., 2022; 17(6): e0268044. doi:10.1371\/journal.pone.0268044.","DOI":"10.1371\/journal.pone.0268044"},{"key":"627124r33","unstructured":"Aksoy N.: Weight Gain After Kidney Transplant. Exp Clin Transplant., 2016;14(Suppl 3): 138\u2013140."},{"key":"627124r34","doi-asserted-by":"crossref","unstructured":"Kurnatowska I., Ma\u0142yska A., Wysocka K. et al.: Long-Term Effect of Body MassIndex Changes on Graft Damage Markers in Patients After Kidney Transplantation.Ann Transplant., 2016; 21: 626\u2013631. doi: 10.12659\/aot.899393.","DOI":"10.12659\/AOT.899393"},{"key":"627124r35","doi-asserted-by":"crossref","unstructured":"Cashion A.K., Hathaway D.K., Stanfill A. et al.: Pre-transplant predictors ofone yr weight gain after kidney transplantation. Clin Transplant., 2014; 28(11):1271\u20131278. doi: 10.1111\/ctr.12456.","DOI":"10.1111\/ctr.12456"},{"key":"627124r36","unstructured":"Post\u0119powanie dietetyczne po transplantacji narz\u0105du (np. nerki) u os\u00f3bw podesz\u0142ym wieku. Warszawski Uniwersytet Medyczny. https:\/\/dieta.wum.edu.pl\/artuku%C5%82\/postepowanie-dietetyczne-po-transplantacji-narzadunp-nerki-u-osob-w-podeszlym-wieku (13.08.2024)."},{"key":"627124r37","doi-asserted-by":"crossref","unstructured":"Khalil M.A.M., Tan J., Khamis S. et al.: Cigarette Smoking and Its Hazards in KidneyTransplantation. Adv Med., 2017; 2017: 6213814. doi: 10.1155\/2017\/6213814.","DOI":"10.1155\/2017\/6213814"},{"key":"627124r38","doi-asserted-by":"crossref","unstructured":"Xia J., Wang L., Ma Z. et al.: Cigarette smoking and chronic kidney disease in thegeneral population: a systematic review and meta-analysis of prospective cohortstudies. Nephrol Dial Transplant., 2017; 32(3): 475\u2013487. doi: 10.1093\/ndt\/gfw452.","DOI":"10.1093\/ndt\/gfw452"},{"key":"627124r39","unstructured":"Nourbala M.H., Nemati E., Rostami Z., Einollahi B.: Impact of cigarette smokingon kidney transplant recipients: a systematic review. Iran J Kidney Dis.,2011; 5(3): 141\u2013148."},{"key":"627124r40","doi-asserted-by":"crossref","unstructured":"Devresse A., Gohy S., Robert A., Kanaan N.: How to manage cigarette smokingin kidney transplant candidates and recipients? Clin Kidney J., 2021; 14(11):2295\u20132303. doi: 10.1093\/ckj\/sfab072.","DOI":"10.1093\/ckj\/sfab072"},{"key":"627124r41","doi-asserted-by":"crossref","unstructured":"Nguyen P.T., Galanti L., Pirson Y., Jadoul M.: Identification of current smokersamong renal transplant recipients. Nephrol Dial Transplant., 2007; 22(7):1974\u20131978. doi: 10.1093\/ndt\/gfl849.","DOI":"10.1093\/ndt\/gfl849"},{"key":"627124r42","doi-asserted-by":"crossref","unstructured":"Kim S.: Overview of Cotinine Cutoff Values for Smoking Status Classification. IntJ Environ Res Public Health., 2016; 13(12): 1236. doi: 10.3390\/ijerph13121236.","DOI":"10.3390\/ijerph13121236"},{"key":"627124r43","doi-asserted-by":"crossref","unstructured":"Sprangers B., Riella L.V., Dierickx D.: Posttransplant Lymphoproliferative DisorderFollowing Kidney Transplantation: A Review. Am J Kidney Dis., 2021;78(2): 272\u2013281. doi: 10.1053\/j.ajkd.2021.01.015.","DOI":"10.1053\/j.ajkd.2021.01.015"},{"key":"627124r44","doi-asserted-by":"crossref","unstructured":"Ponticelli C., Cucchiari D., Graziani G.: Hypertension in kidney transplant recipients.Transpl Int., 2011; 24(6): 523\u2013533. doi: 10.1111\/j.1432-2277.2011.01242.x.","DOI":"10.1111\/j.1432-2277.2011.01242.x"},{"key":"627124r45","doi-asserted-by":"crossref","unstructured":"Kasiske B.L., Anjum S., Shah R. et al.: Hypertension after kidney transplantation.Am J Kidney Dis., 2004; 43(6): 1071\u20131081. doi: 10.1053\/j.ajkd.2004.03.013.","DOI":"10.1053\/j.ajkd.2004.03.013"},{"key":"627124r46","doi-asserted-by":"crossref","unstructured":"Wadei H.M., Textor S.C.: Hypertension in the kidney transplant recipient.Transplant Rev (Orlando)., 2010; 24(3): 105\u2013120. doi: 10.1016\/j.trre.2010.02.001.","DOI":"10.1016\/j.trre.2010.02.001"},{"key":"627124r47","doi-asserted-by":"crossref","unstructured":"Koomans H.A., Ligtenberg G.: Mechanisms and consequences of arterial hypertensionafter renal transplantation. Transplantation., 2001; 72(6 Suppl):S9\u201312. doi: 10.1097\/00007890-200109271-00004.","DOI":"10.1097\/00007890-200109271-00004"},{"key":"627124r48","doi-asserted-by":"crossref","unstructured":"Conte C., Secchi A.: Post-transplantation diabetes in kidney transplant recipients:an update on management and prevention. Acta Diabetol., 2018; 55(8):763\u2013779. doi: 10.1007\/s00592-018-1137-8.","DOI":"10.1007\/s00592-018-1137-8"},{"key":"627124r49","doi-asserted-by":"crossref","unstructured":"Kasiske B.L., Snyder J.J., Gilbertson D., Matas A.J.: Diabetes mellitus after kidneytransplantation in the United States. Am J Transplant., 2003; 3(2): 178\u2013185.doi: 10.1034\/j.1600-6143.2003.00010.x.","DOI":"10.1034\/j.1600-6143.2003.00010.x"},{"key":"627124r50","doi-asserted-by":"crossref","unstructured":"Siraj E.S., Abacan C., Chinnappa P., Wojtowicz J., Braun W.: Risk factors andoutcomes associated with posttransplant diabetes mellitus in kidney transplantrecipients. Transplant Proc., 2010; 42(5): 1685\u20131689. doi: 10.1016\/j.transproceed.2009.12.062.","DOI":"10.1016\/j.transproceed.2009.12.062"},{"key":"627124r51","doi-asserted-by":"crossref","unstructured":"S\u00f8borg A, Reekie J., Rasmussen A. et al.: Trends in underlying causes of deathin solid organ transplant recipients between 2010 and 2020: Using the CLASSmethod for determining specific causes of death. PLoS ONE., 2022; 17(7):e0263210. doi: 10.1371\/journal.pone.0263210.","DOI":"10.1371\/journal.pone.0263210"},{"key":"627124r52","doi-asserted-by":"crossref","unstructured":"Cheung C.Y, Tang S.C.W.: An update on cancer after kidney transplantation.Nephrol Dial Transplant., 2019; 34(6): 914\u2013920. doi: 10.1093\/ndt\/gfy262.","DOI":"10.1093\/ndt\/gfy262"},{"key":"627124r53","doi-asserted-by":"crossref","unstructured":"Zwart E.S., Y\u00fcksel E., Pannekoek A. et al.: De Novo Carcinoma after Solid OrganTransplantation to Give Insight into Carcinogenesis in General-A SystematicReview and Meta-Analysis. Cancers (Basel)., 2021; 13(5): 1122. doi:10.3390\/cancers13051122.","DOI":"10.3390\/cancers13051122"},{"key":"627124r54","doi-asserted-by":"crossref","unstructured":"Vajdic C.M., van Leeuwen M.T.: Cancer incidence and risk factors after solid organtransplantation. Int J Cancer., 2009; 125(8): 1747\u20131754. doi: 10.1002\/ijc.24439.","DOI":"10.1002\/ijc.24439"},{"key":"627124r55","doi-asserted-by":"crossref","unstructured":"Suwalska A., Smolarczyk K., Kosieradzki M., Fiedor P.: Correlation of CancerDevelopment and Human Papilloma Virus Infection in Patients After OrganTransplantation. Transplant Proc., 2020; 52(7): 1982\u20131984. doi: 10.1016\/j.transproceed.2020.03.032.","DOI":"10.1016\/j.transproceed.2020.03.032"},{"key":"627124r56","doi-asserted-by":"crossref","unstructured":"Lee H., Kim Y.H., Lim S.J. et al.: Hepatocellular carcinoma and cancer-relatedmortality after kidney transplantation with rituximab treatment. Ann SurgTreat Res., 2022; 102(1): 55\u201363. doi: 10.4174\/astr.2022.102.1.55.","DOI":"10.4174\/astr.2022.102.1.55"},{"key":"627124r57","doi-asserted-by":"crossref","unstructured":"Einollahi B., Lessan-Pezeshki M., Nourbala M.H. et al.: Kaposi\u2019s sarcoma followingliving donor kidney transplantation: review of 7,939 recipients. Int UrolNephrol., 2009; 41(3): 679\u2013685. doi: 10.1007\/s11255-008-9483-z.","DOI":"10.1007\/s11255-008-9483-z"},{"key":"627124r58","doi-asserted-by":"crossref","unstructured":"Sindrewicz K., K\u0119dzierska-Kapuza K., Jaworowska E., Ciechanowski K.: Prevalenceof Human Papillomavirus Infection in the Head and Neck Area of PatientsAfter Kidney Transplantation Treated With Immunosuppressive Therapy. TransplantProc., 2020; 52(8): 2388\u20132393. doi: 10.1016\/j.transproceed.2020.01.112.","DOI":"10.1016\/j.transproceed.2020.01.112"},{"key":"627124r59","doi-asserted-by":"crossref","unstructured":"Hinten F., Hilbrands L.B., Meeuwis K.A.P. et al.: Reactivation of Latent HPV InfectionsAfter Renal Transplantation. Am J Transplant., 2017; 17(6): 1563\u20131573.doi: 10.1111\/ajt.14181.","DOI":"10.1111\/ajt.14181"},{"key":"627124r60","unstructured":"Lauda\u0144ska E., Brz\u00f3sko S., Biery\u0142o A., Naumnik B.: [Risk factors for cancer developmentin patients after kidney transplantation]. Przegl Lek., 2016; 73(7): 509\u2013512."},{"key":"627124r61","unstructured":"Sun J., Yue Y., Li R. et al.: Detection of HPV E6\/E7 mRNA in the diagnosis ofcervical cancer and precancerous lesions after kidney transplantation. AmJ Transl Res., 2021; 13(6): 7312\u20137317."},{"key":"627124r62","doi-asserted-by":"crossref","unstructured":"Patel H.S., Silver A.R., Northover J.M.: Anal cancer in renal transplant patients.Int J Colorectal Dis., 2007; 22(1): 1\u20135. doi: 10.1007\/s00384-005-0023-3.","DOI":"10.1007\/s00384-005-0023-3"},{"key":"627124r63","doi-asserted-by":"crossref","unstructured":"Reinholdt K., Thomsen L.T., Dehlendorff C. et al.: Human papillomavirusrelatedanogenital premalignancies and cancer in renal transplant recipients:A Danish nationwide, registry-based cohort study. Int J Cancer., 2020; 146(9):2413\u20132422. doi: 10.1002\/ijc.32565.","DOI":"10.1002\/ijc.32565"},{"key":"627124r64","doi-asserted-by":"crossref","unstructured":"Euvrard S., Kanikatis J., Claudy A.: Skin cancer after organ transplantation.N Engl J Med., 2003; 348: 1681\u20131691.","DOI":"10.1056\/NEJMra022137"},{"key":"627124r65","doi-asserted-by":"crossref","unstructured":"O\u2019Reilly Zwald F., Brown M.: Skin cancer in organ transplant recipients: advancesin therapy and management. J Am Acad Dermatol., 2011; 65(2): 253\u2013614.","DOI":"10.1016\/j.jaad.2010.11.062"},{"key":"627124r66","doi-asserted-by":"crossref","unstructured":"Ponticelli C., Cucchiari D., Bencini P.: Skin cancer in kidney transplant recipients.J Nephrol., 2014; 27(4): 385\u2013394. doi: 10.1007\/s40620-014-0098-4.","DOI":"10.1007\/s40620-014-0098-4"},{"key":"627124r67","doi-asserted-by":"crossref","unstructured":"Vasan S.K., Hwang J., Rostgaard K. et al.: ABO blood group and risk of cancer:A register-based cohort study of 1.6 million blood donors. Cancer Epidemiol.,2016; 44: 40\u201343. doi: 10.1016\/j.canep.2016.06.005.","DOI":"10.1016\/j.canep.2016.06.005"},{"key":"627124r68","doi-asserted-by":"crossref","unstructured":"Au E.H., Chapman J.R., Craig J.C. et al.: Overall and Site-Specific Cancer Mortalityin Patients on Dialysis and after Kidney Transplant. J Am Soc Nephrol.,2019; 30(3): 471\u2013480. doi: 10.1681\/ASN.2018090906.","DOI":"10.1681\/ASN.2018090906"},{"key":"627124r69","doi-asserted-by":"crossref","unstructured":"Rosales B.M., De La Mata N., Vajdic C.M., Kelly P.J., Wyburn K., Webster A.C.:Cancer mortality in kidney transplant recipients: An Australian and New Zealandpopulation-based cohort study, 1980-2013. Int J Cancer., 2020; 146(10):2703\u20132711. doi: 10.1002\/ijc.32585.","DOI":"10.1002\/ijc.32585"},{"key":"627124r70","doi-asserted-by":"crossref","unstructured":"Buxeda A., Redondo-Pach\u00f3n D., P\u00e9rez-S\u00e1ez M.J., Crespo M., Pascual J.: Sexdifferences in cancer risk and outcomes after kidney transplantation. TransplantRev (Orlando)., 2021; 35(3): 100625. doi: 10.1016\/j.trre.2021.100625.","DOI":"10.1016\/j.trre.2021.100625"},{"key":"627124r71","doi-asserted-by":"crossref","unstructured":"Krishnan A., Wong G., Teixeira-Pinto A., Lim W.H.: Incidence and Outcomesof Early Cancers After Kidney Transplantation. Transpl Int., 2022; 35: 10024.doi: 10.3389\/ti.2022.10024.","DOI":"10.3389\/ti.2022.10024"},{"key":"627124r72","doi-asserted-by":"crossref","unstructured":"Fr\u00f6hlich F.A., Halleck F., Lehner L. et al.: De-novo malignancies after kidneytransplantation: A long-term observational study. PLoS One., 2020; 15(11):e0242805. doi: 10.1371\/journal.pone.0242805.","DOI":"10.1371\/journal.pone.0242805"},{"key":"627124r73","doi-asserted-by":"crossref","unstructured":"Buell J.F., Gross T.G., Woodle E.S.: Malignancy after transplantation. Transplantation.,2005; 80(2 Suppl): S254\u2013264. doi: 10.1097\/01.tp.0000186382.81130.ba.","DOI":"10.1097\/01.tp.0000186382.81130.ba"},{"key":"627124r74","unstructured":"Krajowy Rejestr Nowotwor\u00f3w, Informacje o danych i s\u0142ownik poj\u0119\u0107. https:\/\/onkologia.org.pl\/pl\/epidemiologia\/informacje-o-danych-i-slownik-pojec(13.08.2024)."},{"key":"627124r75","doi-asserted-by":"crossref","unstructured":"Tessari G., Maggiore U., Zaza G. et al.: Mortality from cancer is not increasedin elderly kidney transplant recipients compared to the general population:a competing risk analysis. J Nephrol., 2020; 33(6): 1309\u20131319. doi: 10.1007\/s40620-020-00847-5.","DOI":"10.1007\/s40620-020-00847-5"},{"key":"627124r76","unstructured":"Penn I., Hammond W., Brettschneider L., Starzl T.E.: Malignant lymphomasin transplantation patients. Transplant Proc., 1969; 1(1): 106\u2013112."},{"key":"627124r77","unstructured":"Israel Penn International Transplant Tumor Registry, About the Registry,https:\/\/ipittr.uc.edu\/about (13.08.2024)."}],"container-title":["Polish Journal of Surgery"],"original-title":[],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T08:19:14Z","timestamp":1744964354000},"score":1,"resource":{"primary":{"URL":"https:\/\/ppch.pl\/gicid\/01.3001.0054.9677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,11,22]]}},"URL":"https:\/\/doi.org\/10.5604\/01.3001.0054.9677","relation":{},"ISSN":["0032-373X","2299-2847"],"issn-type":[{"value":"0032-373X","type":"print"},{"value":"2299-2847","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]}}}